Form 10-Q CATALYST PHARMACEUTICAL For: Jun 30
Tweet
Share
E-mail
http://archive.fast-edgar.com/20140813/A72ZG22FZ22R49ZZ2H2K2ZXRLE5JZZ22ZI62
Filed on: August 13, 2014
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Innovent Biologics Announces First Patient Dosed in a Phase 3 Clinical Trial of IBI3003(GPRC5D/BCMA/CD3 Tri-specific Antibody) for the Treatment of Multiple Myeloma
- Beyond 600 AI Employees: Tec-Do 2.0 Builds an Agent Skill Lab for Enterprise Productivity
- Global Nexa Initiative Launches to Support Climate and Health Innovations
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
